Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram in Functional Dyspepsia
NCT02153567Phase 3Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Dec 2013
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in functional dyspepsia (FD) comparing Escitalopram with Placebo (2 arms). Primary endpoints: Change of serotonin level in blood plasma at 8 weeks and Change of ghrelin level in blood plasma at 8 weeks. Started Dec 2013; status: completed.
02
Drugs
escitalopram
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT02153567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02153567.